31.08.2010
- Genzyme rejected an $18.5 billion takeover offer from French drugmaker Sanofi-Aventis, saying it dramatically undervalues the company. The Cambridge, Massachusetts-based...
30.08.2010
- France's Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme in a bid to rouse shareholders after failing to engage the U.S...
26.08.2010
- Sanofi-Aventis shareholders L'oreal and Total worry that the French drugmaker will pay too much for U.S. biotech company Genzyme and are not convinced it is the best fit, bankers...
26.08.2010
- Sanofi-Aventis is not willing to pay more than $70 per share for U.S. biotech Genzyme and may look at alternative targets, Bloomberg reported on Wednesday, citing sources familiar...
24.08.2010
- U.S. biotechnology firm Genzyme and its French suitor Sanofi-Aventis are at odds over the threshold price at which Sanofi could begin the due diligence on Genzyme's books, the Wall...
23.08.2010
- The lack of new information about Sanofi Aventis' reported interest in acquiring Genzyme could mean the two sides have begun talks, according to Sanford Bernstein analyst Geoffrey...
17.08.2010
- Biotechnology company Genzyme may be holding out for more money from suitor Sanofi-Aventis,but will find it difficult to persuade investors it is better off on its own. France's...
09.08.2010
- Paris-based drugmaker Sanofi-Aventis may need weeks of haggling to get a deal on buying U.S. biotech firm Genzyme as the two appear wide apart over price. Neither party has...
